Citation Tools
Endometrial cancer
272 Dostarlimab in advanced/recurrent mismatch repair deficient/microsatellite instability high or proficient/stable endometrial cancer: the GARNET study
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 272 Dostarlimab in advanced/recurrent mismatch repair deficient/microsatellite instability high or proficient/stable endometrial cancer: the GARNET study